Aktienanalyse zu Cadre Holdings Inc (CDRE)CDRECadre Holdings Inc

Cadre Holdings, Inc. is engaged in the manufacturing and distribution of safety products. The Company's equipment provides protection to allow users to safely perform their duties and protect those around them in hazardous or life-threatening situations. Its core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Its principal body armor product offerings include concealable, corrections and tactical armor, which provide varying levels of protection against ballistic or sharp instrument threats. It offers an engineered portfolio of critical operator survival suits, blast sensors, accessories and vehicle blast attenuation seats for bomb safety technicians, among others. Its engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Its key brands include Safariland and Med-Eng, among others. It operates in the Industrials sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Cadre Holdings Inc is currently not a strong buy due to recent insider selling and declining stock performance, despite analysts projecting a price target of $43, which suggests a potential upside of 40% from the current price of $30.74. The RSI is at 25, indicating the stock is oversold, but the recent 9.91% drop over the last 5 days raises concerns. The main risk is the CEO's recent sale of 75,000 shares, which may signal a lack of confidence in the company's future performance.